Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rasche

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 4, 1977
[Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates (author's transl)]H Rasche, H Bindewald, W Köhle, et al.
Thrombosis and Haemostasis|October 6, 1997
An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trialH Bounameaux, H Ehringer, J Hulting, et al.
Klinische Wochenschrift|February 3, 1986
HTLV III antibodies and immunological alterations in hemophilia patientsE Seifried, G Pindur, H Stötter, et al.
Blut|July 1, 1984
Impaired natural killer cell function in hemophiliacs with or without continuous substitutionF Porzsolt, M Hauser, C Piper, et al.
Scandinavian Journal of Haematology|March 1, 1981
Granulocyte transfusions in acute leukaemia. Regeneration of granulopoiesis as determining factor of survivalH Pflieger, R Arnold, S Bhaduri, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1983
[Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?]H Rasche, J Vollmar, C Burri, et al.
Thrombosis and Haemostasis|May 11, 1999
Differential inhibition of thrombin activity and thrombin generation by a synthetic direct thrombin inhibitor (napsagatran, Ro 46-6240) and unfractionated heparin in patients with deep vein thrombosis. ADVENT InvestigatorsH Bounameaux, H Ehringer, A Gast, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 1982
[Blood clotting factor XIII substitution in acute leukaemia: result of a randomized and controlled study]H Rasche, F Haghou, W Gaus, et al.
Onkologie|June 1, 1979
[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study]M Dietrich, C Abt, R Arnold, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trialF Porzsolt, D Messerer, R Hautmann, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Deutsche Medizinische Wochenschrift (1946)|March 4, 1977
[Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates (author's transl)]H Rasche, H Bindewald, W Köhle, et al.
Thrombosis and Haemostasis|October 6, 1997
An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trialH Bounameaux, H Ehringer, J Hulting, et al.
Klinische Wochenschrift|February 3, 1986
HTLV III antibodies and immunological alterations in hemophilia patientsE Seifried, G Pindur, H Stötter, et al.
Blut|July 1, 1984
Impaired natural killer cell function in hemophiliacs with or without continuous substitutionF Porzsolt, M Hauser, C Piper, et al.
Scandinavian Journal of Haematology|March 1, 1981
Granulocyte transfusions in acute leukaemia. Regeneration of granulopoiesis as determining factor of survivalH Pflieger, R Arnold, S Bhaduri, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1983
[Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?]H Rasche, J Vollmar, C Burri, et al.
Thrombosis and Haemostasis|May 11, 1999
Differential inhibition of thrombin activity and thrombin generation by a synthetic direct thrombin inhibitor (napsagatran, Ro 46-6240) and unfractionated heparin in patients with deep vein thrombosis. ADVENT InvestigatorsH Bounameaux, H Ehringer, A Gast, et al.
Deutsche Medizinische Wochenschrift (1946)|December 10, 1982
[Blood clotting factor XIII substitution in acute leukaemia: result of a randomized and controlled study]H Rasche, F Haghou, W Gaus, et al.
Onkologie|June 1, 1979
[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study]M Dietrich, C Abt, R Arnold, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trialF Porzsolt, D Messerer, R Hautmann, et al.
Pageof 7